Back
Entero Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
1
ENTO
Entero Therapeutics
Last Price:
1.27
Seasonality Move:
-40.72%
Sell
22
NBY
NovaBay Pharmaceuticals
Last Price:
2.20
Seasonality Move:
-15.47%
Sell
1
Entero Therapeutics (ENTO)
is a Sell
Is Entero Therapeutics a Buy, Sell or Hold?
- The current Entero Therapeutics [ENTO] share price is $1.23. The Score for ENTO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- ENTO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $2.21. The Score for NBY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENTO Stock Price Chart
What is Entero Therapeutics's stock price today?
-
The Entero Therapeutics share price today is $1.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTO is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $2.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
ENTO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.35 | Sell |
Relative Strength Index (14 RSI): | 21.27 | Sell |
Chaikin Money Flow: | -29155 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.77 - 2.65) | Sell |
Bollinger Bands (100): | (2.15 - 5.51) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 39.58 | Sell |
Chaikin Money Flow: | -55437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.06 - 4) | Sell |
Bollinger Bands (100): | (2.75 - 4.97) | Sell |
ENTO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.69 | Sell |
20-day SMA: | 2.11 | Sell |
50-day SMA: | 2.52 | Sell |
200-day SMA: | 4.69 | Sell |
8-day EMA: | 1.63 | Sell |
20-day EMA: | 2 | Sell |
50-day EMA: | 2.61 | Sell |
200-day EMA: | 67.66 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.22 | Sell |
20-day SMA: | 2.59 | Sell |
50-day SMA: | 3.18 | Sell |
200-day SMA: | 7.3 | Sell |
8-day EMA: | 2.3 | Sell |
20-day EMA: | 2.66 | Sell |
50-day EMA: | 3.21 | Sell |
200-day EMA: | 14.04 | Sell |
Entero Therapeutics Earnings Growth & ENTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $40.33 per share, and a decrease next year of $0.39 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.48 per share, an increase next quarter of $0.35 per share, an increase this year of $74.90 per share, and an increase next year of $5.60 per share.
Entero Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |